⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL124 | 1.00 | — | — | |
| SCHEMBL1796550 | 1.00 | — | — | |
| SCHEMBL1225018 | 0.82 | — | — | |
| SCHEMBL629993 | 0.82 | — | — | |
| SCHEMBL11846659 | 0.82 | — | — | |
| SCHEMBL11211442 | 0.82 | — | — | |
| SCHEMBL11405620 | 0.82 | — | — | |
| SCHEMBL5399196 | 0.82 | — | — | |
| SCHEMBL11577965 | 0.82 | — | — | |
| SCHEMBL11080219 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120142731-A1 | METHODS OF INHIBITING VIRAL INFECTION | FUNCTIONAL GENETICS, INC. (US) | 2012-06-07 | — | — | US | claimed |
| EP-2203065-A2 | METHODS OF INHIBITING VIRAL INFECTION | Functional Genetics, Inc. (US) | 2010-07-07 | — | — | EP | claimed |
| WO-2009091435-A2 | METHODS OF INHIBITING VIRAL INFECTION | FUNCTIONAL GENETICS, INC. (US) | 2009-07-23 | — | — | WO | claimed |
| US-RE38524-E1 | Dipeptide derivatives as growth hormone secretagogues | PFIZER INC. | 2004-06-01 | — | — | US | claimed |
| US-11873307-B2 | Manufacture of compounds and compositions for inhibiting the activity of SHP2 | NOVARTIS AG (CH) | 2024-01-16 | — | — | US | disclosed |
| EP-4074703-B1 | PYRIDINYL-(AZA)INDOLSULFONAMIDES | UCB PHARMA GMBH (DE) | 2023-11-29 | — | — | EP | disclosed |
| US-20210355134-A1 | MANUFACTURE OF COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF SHP2 | NOVARTIS AG (CH) | 2021-11-18 | — | — | US | disclosed |
| EP-3856744-A1 | MANUFACTURE OF COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF SHP2 | Novartis AG (CH) | 2021-08-04 | — | — | EP | disclosed |
| WO-2020065452-A1 | MANUFACTURE OF COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF SHP2 | NOVARTIS AG (CH) | 2020-04-02 | — | — | WO | disclosed |
| CN-103282358-A | Cyp11b, cyp17, and/or cyp21 inhibitors | BIOMARIN PHARM INC | 2013-09-04 | — | — | CN | disclosed |
| US-20040077654-A1 | Aryl piperidine and piperazine derivatives as inducers of ldl-receptor expression | SMITHKLINE BEECHAM CORPORATION | 2004-04-22 | — | — | US | disclosed |
| EP-1351936-A1 | ARYL PIPERIDINE AND PIPERAZINE DERIVATIVES AS INDUCERS OF LDL-RECEPTOR EXPRESSION | GLAXO GROUP LIMITED (GB) | 2003-10-15 | — | — | EP | disclosed |
| US-5629168-A | Chemiluminescent enhancers | BRITISH TECHNOLOGY GROUP LIMITED (GB) | 1997-05-13 | — | — | US | disclosed |
| US-5079347-A | Fiber reactive dyes for wool and cellulose | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-01-07 | — | — | US | disclosed |
| US-4694005-A | CARDIOTONIC, HYPOTENSIVE | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1987-09-15 | — | — | US | disclosed |
| US-4584298-A | CARDIOTONIC AGENTS, HYPOTENSIVE AGENTS | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1986-04-22 | — | — | US | disclosed |
| US-4539130-A | SULFONATE AND CARBOXYLIC ACID ESTERS, ANHYDRIDES AND IMIDE DERIVATIVES | THE PROCTER & GAMBLE COMPANY (US) | 1985-09-03 | — | — | US | disclosed |
| US-4495185-A | CARDIOTONIC AND/OR HYPOTENSIVE AGENTS | IMPERIAL CHEMICAL INDUSTRIES, PLC (GB) | 1985-01-22 | — | — | US | disclosed |
| US-4489074-A | CARDIOTONIC AGENTS, HYPOTENSIVE AGENTS | IMPERIAL CHEMICAL INDUSTRIES, PLC (GB) | 1984-12-18 | — | — | US | disclosed |
| US-3930671-A | Color former and pressure-sensitive copying paper | FUJI PHOTO FILM CO., LTD. (JA) | 1976-01-06 | — | — | US | disclosed |